1. Market Research
  2. > Biopharmaceutical Industry

Growth Hormone Industry, January 2017 Market Reports from Top Publishers

You might be interested in: Diagnostics, In Vitro Diagnostic Reagent, Biosimilar, Therapy, Protein, Biopharmaceutical, Human Growth Hormone, Injectable Delivery, Biotherapy, Agrochemical, Herbicide, Hormones, Meat, Pharmaceutical, Insulin, Monoclonal Antibody, Protein Engineering.


 
1-10 of 32 reports for Growth Hormone

Purchase Reports From Reputable Market Research Publishers

Growth Hormone Deficiency (GHD)  - Epidemiology Forecast To 2023

Growth Hormone Deficiency (GHD)  - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Growth Hormone Deficiency (GHD)  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Growth Hormone Deficiency (GHD)  in seven major markets (US, France, ...

 Growth Hormone Deficiency-Pipeline Insights, 2017

Growth Hormone Deficiency-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Growth Hormone Deficiency-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Deficiency. ...

Global and Chinese Plant Growth Hormones Industry, 2016 Market Research Report

Global and Chinese Plant Growth Hormones Industry, 2016 Market Research Report

  • $ 2800
  • Industry report
  • December 2016
  • by Prof Research

The ’Global and Chinese Plant Growth Hormones Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Plant Growth Hormones industry with ...

Global and Chinese Human Growth Hormone Industry, 2016 Market Research Report

Global and Chinese Human Growth Hormone Industry, 2016 Market Research Report

  • $ 2800
  • Industry report
  • December 2016
  • by Prof Research

The ’Global and Chinese Human Growth Hormone Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Human Growth Hormone industry with a ...

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Pipeline Review, H2 2016

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Growth Hormone Secretagogue Recepto ...

Medical Affairs Reputations: Growth Hormone Deficiency (EU5)

Medical Affairs Reputations: Growth Hormone Deficiency (EU5)

  • $ 5390
  • Industry report
  • September 2016
  • by Firstword Pharma

Can Medical Affairs teams from branded players maintain dominance over biosimilars? Two medical affairs teams lead in the EU5 growth hormone deficiency (GHD) treatment market, but for how long? Competition ...

Medical Affairs Reputations: Growth Hormone Deficiency (US)

Medical Affairs Reputations: Growth Hormone Deficiency (US)

  • $ 5390
  • Industry report
  • September 2016
  • by Firstword Pharma

Two Medical Affairs teams lead the market. Can your team learn from their success? Two medical affairs teams have the lead in the US growth hormone deficiency (GHD) treatment market, with the third placed ...

NPS+ Growth Hormone Deficiency (GHD)  (EU5)

NPS+ Growth Hormone Deficiency (GHD) (EU5)

  • $ 2668
  • Industry report
  • July 2016
  • by Firstword Pharma

Just one brand shows a positive Net Promoter Score in the EU: fertile ground for other brands to gain share? EU endocrinologists are not overly satisfied with current growth hormone deficiency treatment ...

NPS+ Growth Hormone Deficiency (GHD) (US)

NPS+ Growth Hormone Deficiency (GHD) (US)

  • $ 2668
  • Industry report
  • July 2016
  • by Firstword Pharma

Could differentiation efforts boost some GHD brands in the US? Opportunity lurks in the US Growth hormone Deficiency treatment landscape. Although 3 established brands dominate, promoters of these brands ...

Next-Generation Biologics Market 2016-2026: Revenue Forecasts and R&D Trends for Therapeutic Antibody Technologies, Insulins, Growth Hormones, Recombinant Coagulation Factors and Regenerative Medicine

Next-Generation Biologics Market 2016-2026: Revenue Forecasts and R&D Trends for Therapeutic Antibody Technologies, Insulins, Growth Hormones, Recombinant Coagulation Factors and Regenerative Medicine

  • $ 2508
  • Industry report
  • May 2016
  • by Visiongain

Report Details Emerging Biological Drugs – This New Study Reveals Selling Opportunities and Revenue Prospects to Help You Stay Ahead What is the future of biologics, especially new drug classes? Now ...

About 2400 reports for Growth Hormone

Download Unlimited Documents from Trusted Public Sources

Growth Hormone Industry in the US

  • January 2017
    17 pages
  • Growth Hormone  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.